| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |